Risk levels for drinking established by the WHO, which are now used in FDA clinical trials for AUD therapies, were also noted to decline by two levels in the semaglutide group after 26 weeks of therapy
34 LiangF.TianX.DingL
So first the trial and Im just going to cut and paste from Lillys pressor on this part as to what the trial actually is: TRIUMPH-4 (NCT05869903) is a Phase 3, 68-week, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of retatrutide with placebo in adults with obesity or overweight and knee osteoarthritis
The ban on compounded semaglutide initiated the same response
A close reading of the statute, however, reveals that the law appears to be ambiguous, and does not squarely support their interpretation
Side effects may vary depending on the form of semaglutide you use